The assembly of F(1)F(O)-ATP synthase is disrupted upon interference of RNA editing in Trypanosoma brucei.
Throughout eukaryotes, the gene encoding subunit 6 (ATP6) of the F(1)F(O)-ATP synthase (complex V) is maintained in mitochondrial (mt) genomes, presumably because of its high hydrophobicity due to its incorporation into the membrane-bound F(O) moiety. In Trypanosoma species, a mt transcript that undergoes extensive processing by RNA editing has a very low sequence similarity to ATP6 from other organisms. The notion that the putative ATP6 subunit is assembled into the F(O) sub-complex is ostensibly challenged by the existence of naturally occurring dyskinetoplastic (Dk) and akinetoplastid (Ak) trypanosomes, which are viable despite lacking the mtDNA required for its expression. Taking advantage of the different phenotypes between RNA interference knock-down cell lines in which the expression of proteins involved in mtRNA metabolism and editing can be silenced, we provide support for the view that ATP6 is encoded in the mt genome of Trypanosoma species and that it is incorporated into complex V. The reduction of the F(1)F(O) oligomer of complex V coincides with the accumulation of the F(1) moiety in ATP6-lacking cells, which also appear to lack the F(O) ATP9 multimeric ring. The oligomycin sensitivity of ATPase activity of complex V in ATP6-lacking cells is reduced, reflecting the insensitivity of the Dk and Ak cells to this drug. In addition, the F(1) moiety of complex V appears to exist as a dimer in steady state conditions and contains the ATP4 subunit traditionally assigned to the F(O) sub-complex.
Hashimi
Hassan
H
Biology Centre, Institute of Parasitology, Czech Academy of Sciences, and Faculty of Biology, University of South Bohemia, 37005 Ceské Budejovice (Budweis), Czech Republic.
Benkovicová
Vladislava
V
Cermáková
Petra
P
Lai
De-Hua
DH
Horváth
Anton
A
Lukes
Julius
J
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008564:Membrane Potentials; D008928:Mitochondria / Q000235:genetics / Q000378:metabolism; D009840:Oligomycins / Q000494:pharmacology; D006180:Proton-Translocating ATPases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*; D015800:Protozoan Proteins / Q000235:genetics / Q000378:metabolism; D017393:RNA Editing; D034622:RNA Interference; D014346:Trypanosoma brucei brucei / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000254:growth & development
D004791:Enzyme Inhibitors; D009840:Oligomycins; D015800:Protozoan Proteins; D006180:Proton-Translocating ATPases